Is ARCT stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Arcturus Therapeutics pays dividends. Last time was Tuesday 15th of January 2013 where the investors holding the stock on Tuesday 8th of January 2013 were paid $0.00850 per share. Over the last 12 times between 2012 and 2013, Arcturus Therapeutics has paid $0.0973 with an average of $0.01 per share.
Sorry, we do not have any analyst data for this ticker
On Friday 17th of October 2014, Arcturus Therapeutics had a stock price of $37.80. If you invested back then, your return now would be a loss of $-17.17 per share or -45.42%
Yes, the average daily trading liquidity for Arcturus Therapeutics is $12.61 million. You should therefore be able to get in and out of your positions relatively fast.
Arcturus Therapeutics has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Arcturus Therapeutics to be medium [0.7 out of 1]